Skip to content
value.today

Crescent Biopharma, Inc. vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $195 M for Crescent Biopharma, Inc., 462 times as much (market caps of Jan 5, 2024 for Crescent Biopharma, Inc. and Oct 30, 2026 for Moderna, Inc.). Crescent Biopharma, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B against $11 M for Crescent Biopharma, Inc., both in the year to December 2025.
  • Both made a net loss: $154 M for Crescent Biopharma, Inc. and $2.8 B for Moderna, Inc.
  • Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -1420.1% for Crescent Biopharma, Inc.
  • Moderna, Inc. employs more people: 4,700 against 44 at Crescent Biopharma, Inc. Each employee brings in about $246,364 of revenue at Crescent Biopharma, Inc. and $413,617 at Moderna, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Crescent Biopharma, Inc. 87Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Crescent Biopharma, Inc. $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCrescent Biopharma, Inc.
CBIO
Moderna, Inc.
MRNA · #275 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20032010
Size
Market cap$195 M*$90.1 B
Revenue$11 M$1.9 B
Net income$-154 M▲ best$-2.8 B
Employees444,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity-164.2%-28.9%▲ best
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin-668.4%-106.2%▲ best
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Jan 2024; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Crescent Biopharma, Inc. or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $195 M for Crescent Biopharma, Inc., 462 times as much (market caps of Jan 5, 2024 for Crescent Biopharma, Inc. and Oct 30, 2026 for Moderna, Inc.). Crescent Biopharma, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Crescent Biopharma, Inc. or Moderna, Inc.?

Moderna, Inc. had more revenue: $1.9 B against $11 M for Crescent Biopharma, Inc., both in the year to December 2025. Both made a net loss: $154 M for Crescent Biopharma, Inc. and $2.8 B for Moderna, Inc.

Which is more profitable, Crescent Biopharma, Inc. or Moderna, Inc.?

Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -1420.1% for Crescent Biopharma, Inc.

Which has more employees, Crescent Biopharma, Inc. or Moderna, Inc.?

Moderna, Inc. employs more people: 4,700 against 44 at Crescent Biopharma, Inc. Each employee brings in about $246,364 of revenue at Crescent Biopharma, Inc. and $413,617 at Moderna, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.